NCT00342407
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +19 more
- Locations
-
- National Institute for Occupational Safety and Health (NIOSH) Cincinnati, Ohio, United States
Clinical trial condition
Endocrine Gland Neoplasms
Explore clinical trials studying Endocrine Gland Neoplasms. Study availability and eligibility vary by location and protocol.
6,100 public trials
1,371 recruiting studies
Endocrine Gland Neoplasms trial results
NCT02698137
- Conditions
- Bile Duct and Pancreatic Tumors, Biliary Strictures, Cholangiopancreatography, Endoscopic Retrograde, +9 more
- Locations
-
- GI Endoscopy Unit, Department of Gastroenterology and Hepatology, University Hospital Zagreb Zagreb, Croatia
- Endoscopia Digestiva Chirurgica, Policlinico Gemelli Roma, Italy
- Gastroenterology Department, Colentina Hospital Bucharest, Romania
Completed
Erlotinib and Carboplatin in Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT00030446
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
- Locations
-
- Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada
- British Columbia Cancer Agency - Centre for the Southern Interior Kelowna, British Columbia, Canada
- British Columbia Cancer Agency Vancouver, British Columbia, Canada
- Queen Elizabeth II Health Science Centre Halifax, Nova Scotia, Canada
Completed
The Platinum Study Comparison Group
NCT02890030
- Conditions
- Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Ear Diseases, +22 more
- Locations
-
- Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
NCT03781453
- Conditions
- Behavior, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine Gland Neoplasms, +12 more
- Locations
-
- Shell Canada Ltd (Scotford Site) Ft Saskatchewan, Alberta, Canada
- Roper Ventures Rocky Mountain House, Alberta, Canada
- PeroxyChem Prince George, British Columbia, Canada
Completed
Lurtotecan Liposome in Treating Patients With Advanced or Recurrent Ovarian Epithelial Cancer
NCT00010179
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
- Locations
-
- Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada
- BCCC - Cancer Center for the Southern Interior Kelowna, British Columbia, Canada
- British Columbia Cancer Agency Vancouver, British Columbia, Canada
- CancerCare Manitoba Winnipeg, Manitoba, Canada
Completed
Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors
NCT00006036
- Conditions
- Adnexal Diseases, Bronchial Neoplasms, Carcinoma, +50 more
- Locations
-
- British Columbia Cancer Agency Vancouver, British Columbia, Canada
- Cancer Care Ontario-Hamilton Regional Cancer Centre Hamilton, Ontario, Canada
- Toronto General Hospital Toronto, Ontario, Canada
NCT00003892
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +17 more
- Locations
-
- Duluth Clinic Duluth, Minnesota, United States
- Memorial Sloan-Kettering Cancer Center New York, United States
- Cross Cancer Institute Edmonton, Alberta, Canada
- Lethbridge Cancer Clinic Lethbridge, Alberta, Canada
NCT02421588
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
- Locations
-
- 1112 Peoria, Arizona, United States
- 1102 Greenbrae, California, United States
- 1103 La Jolla, California, United States
- 1116 Los Angeles, California, United States
NCT00016380
- Conditions
- Adenocarcinoma, Adnexal Diseases, Appendiceal Neoplasms, +55 more
- Locations
-
- Cross Cancer Institute Edmonton, Alberta, Canada
- British Columbia Cancer Agency - Centre for the Southern Interior Kelowna, British Columbia, Canada
- Fraser Valley Cancer Centre at British Columbia Cancer Agency Surrey, British Columbia, Canada
- British Columbia Cancer Agency Vancouver, British Columbia, Canada